Kylie Jenner is the latest A-lister hopping on the stem cell therapy bandwagon. The 28-year-old mom of two revealed that she ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...

The U.S. Food and Drug Administration (FDA) has approved Breyanzi (lisocabtagene maraleucel) for the treatment of adults with relapsed or refractory marginal zone lymphoma who have received at least ...

Four months after her sisters Kim and Khloe Kardashian underwent a comparable procedure with the same doctor, Kylie’s ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

Review of recent advances in biomimetic drug delivery for rheumatoid arthritis, highlighting targeted nanomedicine strategies ...

The Kardashian sister wrote on Instagram that she had been dealing with chronic back pain for nearly three years, after ...

A study from the Hospital del Mar Research Institute, published in The Journal of Clinical Investigation, indicates that the high expression of the estrogen receptor is the main factor preventing the ...

Lynk received the green light from the FDA to begin clinical trials of its investigational oral therapy LNK01006 for MS and ...

Advanced therapies have helped boost the 5-year survival rates for some cancers above 90%. But many other forms remain difficult to treat, and 'there aren't many good drugs.' ...

For the first time, chemists have fully synthesized verticillin A, a notoriously complex fungal molecule with striking anticancer potential.

Beam Therapeutics Inc. is a Strong Buy with promising trial results, a solid cash runway, and key data updates ahead. Click ...